semaglutide compounding fda enforcement today free to pursue compounders after latest court ruling Novo Nordisk protects US patients

Compounded versions use generic names: semaglutide and tirzepatide

If your side effects are severe or persistent, your healthcare provider can adjust your dose, change your timing, or explore other management strategies

Furthermore, our analysis involved two different time points at 180 and 360 days for both treatment persistence and adherence, which is important in informing medium- and longer-term persistence and adherence

Recent clinical trials have shown that GLP-1 receptor agonists like semaglutide can meaningfully slow glucose progression and reduce diabetes risk by up to 56% in some populations

Despite these findings and explicit advice against using GLP-1 agonist therapy in individuals with similar symptoms, Novo Nordisk failed to inform doctors about this potential issue or update their prescribing guidelines